share_log

Nanalysis Announces Full Year 2023 Conference Call

Nanalysis Announces Full Year 2023 Conference Call

Nanalysis宣佈2023年全年電話會議
PR Newswire ·  04/11 20:30

Hosting Call at 5:00 pm ET on Thursday, April 25th

4月25日星期四美國東部時間下午 5:00 舉行主機電話會議

European Q&A Session on Friday April 26th at 8:30am ET

4月26日星期五歐洲問答環節第四 美國東部時間上午 8:30

CALGARY, AB, April 11, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces that on Thursday, April 25th, 2024, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter and year ending December 31, 2023.

艾伯塔省卡爾加里,2024年4月11日 /PRNewswire/-用於工業和研究應用的便攜式核磁共振機器和核磁共振成像技術的領導者Nanalysis Scientific Corp.(“公司”)(TCQX:NSCI)(FRA:1N1)宣佈,該公司將於2024年4月25日星期四發佈新聞稿,蘭德首席執行官肖恩·克拉基夫斯基和首席財務官 All McRae將在美國東部時間下午5點主持電話會議,討論截至2023年12月31日的季度和年度的業績。

Investors interested in participating in the live full year call can dial 1-888-664-6392 or 416-764-8659 from abroad. Investors can also access the call online through a listen-only webcast here: or on the investor relations section of the Company's website HERE.

有興趣參與全年電話會議的投資者可以從國外撥打1-888-664-6392或416-764-8659。投資者還可以在此處通過僅限收聽的網絡直播在線觀看電話會議:或在此處訪問公司網站的投資者關係部分。

The webcast will be archived on the Company's investor relations webpage for at least 90 days and a telephonic playback will be available for seven days after the conference call by calling 1-888-390-0541 or 416-764-8677, conference ID # 093791.

該網絡直播將在公司的投資者關係網頁上存檔至少90天,電話會議結束後的七天內將通過致電1-888-390-0541或416-764-8677進行電話回放,會議編號爲093791。

Additionally, the Company will be hosting a Q&A session for it's European investors at 8:30am ET on Friday, April 26th which can be accessed by the following link: Join the meeting now

此外,該公司將於美國東部時間4月26日星期五上午8點30分爲其歐洲投資者舉辦問答環節,可通過以下鏈接訪問: 立即加入會議

About
關於
Nanalysis Scientific Corp.
Nanalysis 科學公司
(TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)
(TSXV: NSCI,場外交易所:NSCIF,FRA: 1N1)

Nanalysis Scientific Corp. operates two primary businesses: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60 was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz device, the most powerful and most advanced compact NMR device ever brought to market.

Nanalysis Scientific Corp. 經營兩項主要業務:科學設備和安全服務。在其科學設備業務中,公司稱之爲 “工業用磁共振和核磁共振”。該公司爲實驗室和工業市場開發和製造便攜式核磁共振(NMR)光譜儀或分析儀。NMReady-60 是第一款功能齊全的便攜式 NMR 光譜儀,採用緊湊的外殼,無需液氦或任何其他低溫劑。該公司在首次發行後推出了新產品,並繼續擁有強大的創新渠道。2020年,該公司宣佈推出其100MHz設備,這是有史以來推向市場的最強大、最先進的緊湊型核磁共振設備。

The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners. With its partners, the Company provides scientific equipment sales and maintenance services globally.

該公司的設備用於許多行業(石油和天然氣、化工、採礦、製藥、生物技術、香精和香料、農用化學品、執法等)以及世界各地的衆多政府和大學研究實驗室。公司繼續獨立並與合作伙伴一起開拓新的全球市場機會。公司與合作伙伴一起在全球範圍內提供科學設備銷售和維護服務。

In 2022, through its subsidiary KPrime, the Company was awarded a five-year, $160 million contract with the Government of Canada to provide maintenance services for passenger screening equipment in Canadian airports. This has resulted in the expansion of the Company's Security Services business. The Company is providing airport security equipment maintenance services for the Government of Canada in each province and territory of Canada. In addition, the Company provides commercial security equipment installation and maintenance services to a variety of customers in North America.

2022年,該公司通過其子公司KPrime與加拿大政府簽訂了一份爲期五年、價值1.6億美元的合同,爲加拿大機場的旅客安檢設備提供維護服務。這導致了公司安全服務業務的擴展。該公司在加拿大各省和地區爲加拿大政府提供機場安全設備維護服務。此外,該公司爲北美的各種客戶提供商用安全設備安裝和維護服務。

Notice regarding Forward Looking Statements and Legal Disclaimer
關於前瞻性陳述和法律免責聲明的通知

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

本新聞稿包含適用證券法下此類陳述所指的某些 “前瞻性陳述”。前瞻性陳述通常以 “預期”、“計劃”、“繼續”、“期望”、“項目”、“打算”、“相信”、“預期”、“估計”、“可能”、“將來”、“潛在”、“提議”、“定位” 等詞語來表徵,或某些事件或條件 “可能” 或 “將” 發生的陳述。這些陳述只是預測。在本新聞稿的前瞻性陳述中得出結論或做出預測時,使用了各種假設。前瞻性陳述基於管理層在陳述發表之日的觀點和估計,受各種風險和不確定性以及其他因素的影響,這些因素可能導致實際事件或結果與前瞻性陳述中的預測存在重大差異。除非適用法律明確要求,否則公司沒有義務更新或修改任何前瞻性陳述,也明確表示不打算或義務更新或修改任何前瞻性陳述,無論是由於新信息、未來事件還是其他原因。

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

TSX Venture Exchange及其監管服務提供商均不對本新聞稿的充分性或準確性承擔責任。

SOURCE Nanalysis Scientific Corp.

來源 Nanalysis 科學公司

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論